Skip to main content
Matty Rypto Photo
Mahathir Bayena

Mahathir Bayena

GrafaCrypto Journalist

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.

Articles by Mahathir Bayena

Grafa

CervoMed completes Phase 2a trial enrollment for rare frontotemporal dementia candidate

CervoMed (NASDAQ:CRVO), a clinical-stage biotechnology company focused on treating age-related brain disorders, announced today that it has finalized patient enrollment for its Phase 2a clinical trial evaluating its lead drug candidate, neflamapimod, in individuals with nonfluent variant primary progressive aphasia (nfvPPA).

Read more: CervoMed completes Phase 2a trial enrollment for rare frontotemporal dementia candidate